Picture of Eurofins Scientific SE logo

ERF — Eurofins Scientific SE News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Eurofins Scientific slips after FY revenue, organic growth miss

** Shares in Eurofins Scientific  EUFI.PA  slip around 3%
after the Luxembourg-based company reported lower than expected
FY revenue and organic growth short of its own guidance
    ** FY revenue came in at 6.95 billion euros ($7.24 billion)
vs IBES estimate of 6.97 billion
    ** Midcap Partners notes the organic growth of 4.7% was
"significantly" below the company's own forecast of 6.5% growth
announced in the 2027 plan
    ** Broker says the group's performance is "still off the
mark", adding it struggles with continued weak level of organic
growth, issues with governance and "unconvincing" operational
leverage
    ** "Eurofins still seems uninvestable to us," says Midcap
    ** The stock is among top losers on French blue chip index
CAC40  .FCHI 
 


($1 = 0.9598 euros)

 (Reporting by Mateusz Rabiega)
 ((Mateusz.rabiega@thomsonreuters.com))

Recent news on Eurofins Scientific SE

See all news